THF-DIOL STIMULATION OF PLA2, LOX AND COX GENE EXPRESSION
THF-DIOL STIMULATION OF PLA2, LOX AND COX GENE EXPRESSION
批准号:
7721564
负责人:
BARRY Matthew MARKAVERICH
金额:
$2.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2009-01-31
关键词:
AcidsAffectAromataseBedsBreast Cancer CellCell ProliferationComputer Retrieval of Information on Scientific Projects DatabaseCoupledEndocrine DisruptorsEnzyme InhibitionEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesEstradiolEstrogen receptor negativeEstrogen receptor positiveFemaleFormestaneFundingGene ExpressionGenetic TranscriptionGlycolGrantHydroxyeicosatetraenoic AcidsIn VitroIndomethacinInstitutionLOX geneLinoleic AcidsLipoxygenaseMCF7 cellMediatingMetabolismMethodsMitogensNordihydroguaiaretic AcidOralOvarianPTGS2 genePathway interactionsPeriodicityPhospholipase A2Polymerase Chain ReactionProstaglandin-Endoperoxide SynthaseProstaglandinsProtein-Lysine 6-OxidaseProteinsQuinacrineRNARattusRegulationResearchResearch PersonnelResourcesSex BehaviorSiteSourceStearic AcidsTimeUnited States National Institutes of HealthWestern Blottingabstractingbaicaleincancer cellcyclooxygenase 1cyclooxygenase 2malephospholipase A2 inhibitorresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Abstract:
Background: We characterized an endocrine disrupter from ground corncob bedding material that interferes with male and female sexual behavior and ovarian cyclicity in rats and stimulates estrogen receptor (ER)-positive and ER-negative breast cancer cell proliferation. The agents were identified as an isomeric mixture of THF-diols (9, 12-oxy-10, 13-dihydroxyoctadecanoic acid and 10, 13-oxy, 9, 12-dihydroxy-octadecanoic acid). Synthetic THF-diols inhibited rat male and female sexual behavior at oral concentrations of 0.5 to 1 ppm, and stimulated MCF-7 human breast cancer cell proliferation in vitro.
Objectives: Since THF-diols are derived from lipoxygenase and cyclooxygenase pathways, we suspected that these compounds may regulate cell proliferation by modulating specific enzymatic sites involved in linoleic acid metabolism including phospholipase A2 (PLA2), lipoxygenases (LOX-5 and LOX-12), cyclooxygenases (COX-1 and COX-2) and closely coupled enzymes including aromatase.
Methods: MCF-7 human breast cancer cells were treated with inhibitors for phospholipase A2 (PLA2; Quinacrine), lipoxygenases (LOX-5 and LOX-12; Baicalein, Rev 5091, NDGA), cyclooxygenases (COX-1, COX-2, Indomethacin) and aromatase (Formestane). The effects of these enzyme inhibitors on cell proliferation in response to THF-diols or estradiol (E2) were assessed. THF-diol modulation of the expression (RNA and protein) of these enzymes was also evaluated by real time PCR (QPCR) and Western blot analyses.
Results: The enzyme inhibition and gene expression (RNA and protein) studies identified PLA2, LOX-5, LOX-12 and COX-2 and perhaps aromatase as likely sites of THF-diol regulation in MCF-7 cells. COX-1 was not affected by THF-diol treatment.
Discussion: THF-diol stimulation of MCF-7 cell proliferation is mediated through effects on the expression and/or activities of PLA2, COX-2, LOX-5 and LOX-12. As the products of these enzymes, including prostaglandins, hydroxyeicosatetraenoic acids (HETE's) and hydroxyoctadecenoic acids (HODE's), are well-established mitogens in normal and malignant cells, it is likely that these compounds are involved in the mechanism of action of THF-diols in breast cancer cells. Although the Formestane inhibition studies suggested that aromatase activity may be modulated by THF-diols, this was not confirmed by the gene expression studies.
Key Words: THF-diols, PLA2, COX-2, LOX-5, LOX-12 gene expression, breast cancer cell proliferation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer
-
批准号:8403630
-
项目类别:
-
资助金额:$29.04万
-
财政年份:2009
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
THF-DIOL STIMULATION OF PLA2, LOX AND COX GENE EXPRESSION
-
批准号:7953969
-
项目类别:
-
资助金额:$1.45万
-
财政年份:2009
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer
-
批准号:8006439
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2009
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer
-
批准号:8204469
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2009
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
TETRAHYDROFURAN-DIOLS AND ENDOCRINE DISRUPTION IN ADULT RATS
-
批准号:7953932
-
项目类别:
-
资助金额:$0.42万
-
财政年份:2009
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer
-
批准号:7569613
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2009
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer
-
批准号:7749563
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2009
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
TETRAHYDROFURAN-DIOLS AND ENDOCRINE DISRUPTION IN ADULT RATS
-
批准号:7721504
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2008
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
LEUKOTOXIN DIOL FROM CORN COB ANIMAL BEDDING STIMULATES BREAST CANCER CELLS
-
批准号:7355163
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2006
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
NOVEL ENDOCRINE DISRUPTING AGENT IN CORN THAT STIMULATES BREAST CANCER CELLS
-
批准号:7180101
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2005
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
NOVEL ENDOCRINE DISRUPTING AGENT IN CORN THAT STIMULATES BREAST CANCER CELLS
-
批准号:6977078
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2003
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER
-
批准号:6929288
-
项目类别:
-
资助金额:$24.26万
-
财政年份:1999
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER
-
批准号:7271119
-
项目类别:
-
资助金额:$30.5万
-
财政年份:1999
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER
-
批准号:2885770
-
项目类别:
-
资助金额:$22.74万
-
财政年份:1999
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER
-
批准号:6178786
-
项目类别:
-
资助金额:$22.04万
-
财政年份:1999
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER
-
批准号:7121085
-
项目类别:
-
资助金额:$31.41万
-
财政年份:1999
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER
-
批准号:6720313
-
项目类别:
-
资助金额:$33.27万
-
财政年份:1999
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER
-
批准号:6382314
-
项目类别:
-
资助金额:$22.7万
-
财政年份:1999
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER
-
批准号:6803232
-
项目类别:
-
资助金额:$32.8万
-
财政年份:1999
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
ANTITUMOR ACTIVITY OF MEHPLA RELATED ENONES
-
批准号:2096715
-
项目类别:
-
资助金额:$19.47万
-
财政年份:1992
-
负责人:BARRY Matthew MARKAVERICH
-
依托单位:
海外基金